MYC and osteosarcoma: The results showed that the abundances of CD4+ and CD8+ cells inside tumors were dramatically increased after JQ-1 administration (Fig. 3A, B), indicating that pharmacological inhibition of c-Myc can enhance T cell infiltration in osteosarcoma.